Abstract | BACKGROUND: PATIENTS AND METHODS: A cross-sectional study was made in a representative sample of 147 hospitalized women aged from 15 to 60 years. The incidence of adverse skin reactions, diabetes, hypertension and serum creatinine in 41 women admitting use of depigmenting agents was compared to those found in 85 women who maintained they had never used depigmenting agents. Two patients who refused to participate in the study and 19 others who did use depigmenting products and had stopped their use for at least 3 months were excluded from the analysis. RESULTS: DISCUSSION: The prevalence of use of depigmenting agents in this first published hospital series confirms the widespread nature of this phenomenon in Senegal. While certain patent skin signs are similar to those described in the literature, and excluding specific features related to the hospital setting, this is the first report of a dose-effect between use of depigmentation agents and diabetes and hypertension, probably via the effect of topical steroids.
|
Authors | E Raynaud, C Cellier, J L Perret |
Journal | Annales de dermatologie et de venereologie
(Ann Dermatol Venereol)
2001 Jun-Jul
Vol. 128
Issue 6-7
Pg. 720-4
ISSN: 0151-9638 [Print] France |
Vernacular Title | Dépigmentation cutanée à visée cosmétique. |
PMID | 11460033
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents
- Cosmetics
- Glucocorticoids
- Hydroquinones
- hydroquinone
|
Topics |
- Administration, Topical
- Adolescent
- Adult
- Anti-Inflammatory Agents
(administration & dosage, adverse effects)
- Black People
- Cosmetics
(adverse effects)
- Cross-Sectional Studies
- Drug Eruptions
(epidemiology, etiology)
- Female
- Glucocorticoids
- Humans
- Hydroquinones
(administration & dosage, adverse effects)
- Middle Aged
- Pigmentation Disorders
(chemically induced, epidemiology)
- Risk Factors
- Senegal
- Skin Diseases, Infectious
(chemically induced, epidemiology)
- Skin Pigmentation
(drug effects)
|